High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene

Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations

Medicine, Genetics, Oncology +14

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

Medicine, Oncology, Pharmacology +10

Markers of Inflammation and Cardiovascular Disease

Thomas A. Pearson, George A. Mensah, R. Wayne Alexander et al. · Circulation · 2003 · 6.4K citations · Full text

Medicine, Cardiology, Physical Medicine +14

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Paul M. Ridker, Charles H. Hennekens, Julie E. Buring et al. · New England Journal of Medicine · 2000 · 5.9K citations · Full text

Medicine, Cardiology, Clinical Sciences +15

The cardiovascular health study: Design and rationale

Linda P. Fried, Nemat O. Borhani, Paul Enright et al. · Annals of Epidemiology · 1991 · 3.7K citations

Medicine, Cardiology, Clinical Cardiology +5